HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Erin M Jonaitis Selected Research

Apolipoproteins E (ApoE)

1/2023Harnessing cognitive trajectory clusterings to examine subclinical decline risk factors.
1/2019Characterizing the Effects of Sex, APOE ɛ4, and Literacy on Mid-life Cognitive Trajectories: Application of Information-Theoretic Model Averaging and Multi-model Inference Techniques to the Wisconsin Registry for Alzheimer's Prevention Study.
1/2018The Wisconsin Registry for Alzheimer's Prevention: A review of findings and current directions.
1/2013Interaction between two cholesterol metabolism genes influences memory: findings from the Wisconsin Registry for Alzheimer's Prevention.
7/2011The effect of TOMM40 poly-T length on gray matter volume and cognition in middle-aged persons with APOE ε3/ε3 genotype.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Erin M Jonaitis Research Topics

Disease

29Alzheimer Disease (Alzheimer's Disease)
03/2024 - 07/2011
16Cognitive Dysfunction
01/2024 - 01/2018
5Dementia (Dementias)
01/2023 - 01/2019
5Insulin Resistance
01/2021 - 02/2013
4Disease Progression
07/2023 - 01/2022
4Atrophy
01/2023 - 01/2019
2Genetic Risk Score
02/2023 - 01/2023
2Amyloidosis
01/2022 - 12/2019
1Neuroinflammatory Diseases
05/2023
1Vascular Diseases (Vascular Disease)
01/2023
1Neurodegenerative Diseases (Neurodegenerative Disease)
01/2023
1Proteostasis Deficiencies
01/2023
1Neurobehavioral Manifestations
11/2022
1Amyloid Plaque
01/2022
1Type 2 Diabetes Mellitus (MODY)
01/2021
1Dysthymic Disorder
01/2020
1Hyperglycemia
05/2015
1Abdominal Obesity
07/2013

Drug/Important Bio-Agent (IBA)

26Biomarkers (Surrogate Marker)IBA
03/2024 - 01/2018
13Amyloid (Amyloid Fibrils)IBA
01/2024 - 05/2015
5Glucose (Dextrose)FDA LinkGeneric
05/2023 - 02/2013
5Apolipoproteins E (ApoE)IBA
01/2023 - 07/2011
4Amyloid beta-PeptidesIBA
01/2024 - 10/2020
4ApolipoproteinsIBA
01/2022 - 07/2011
2Proteins (Proteins, Gene)FDA Link
05/2023 - 01/2019
22- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA
01/2023 - 01/2020
1ProteomeIBA
05/2023
1Amyloidogenic ProteinsIBA
05/2023
1CarbonIBA
05/2023
1Edetic Acid (EDTA)FDA Link
01/2022
1Heparin (Liquaemin)FDA LinkGeneric
01/2022
1Chitinase-3-Like Protein 1IBA
01/2021
1Glial Fibrillary Acidic ProteinIBA
01/2021
1Indicators and Reagents (Reagents)IBA
01/2021
1Interleukin-6 (Interleukin 6)IBA
01/2021
1NeurograninIBA
01/2021
1SynucleinsIBA
01/2021
1Calcium-Binding ProteinsIBA
01/2021
1Insulin (Novolin)FDA Link
09/2015
1HDL CholesterolIBA
07/2013
1Triglycerides (Triacylglycerol)IBA
07/2013

Therapy/Procedure

1Secondary Prevention
01/2023
1Therapeutics
12/2022
1Activities of Daily Living (ADL)
01/2020